Abirapro 250 mg Tablet is a prescription androgen biosynthesis inhibitor indicated for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and metastatic castration-sensitive prostate cancer (mCSPC) in appropriate patients. It contains Abiraterone Acetate 250 mg, the same active pharmaceutical ingredient as Zytiga, the originator brand developed by Janssen Biotech (Johnson & Johnson). Abiraterone has become one of the most important targeted hormonal therapies in prostate cancer treatment and is prescribed extensively across the United States, United Kingdom, Europe, Canada, and Australia.
Abiraterone works by selectively inhibiting the CYP17 enzyme, a critical component in androgen production. By reducing the synthesis of testosterone and other androgens in the testes, adrenal glands, and tumor tissues, Abiraterone helps slow the growth and progression of prostate cancer cells. Due to its mechanism of action, it is routinely administered alongside low-dose prednisone to help manage mineralocorticoid-related adverse effects.
Abirapro 250 mg Tablet is commonly prescribed for patients with advanced prostate cancer, particularly those with metastatic disease requiring long-term hormone therapy. It has significantly changed treatment outcomes in modern oncology and is frequently incorporated into comprehensive prostate cancer management strategies alongside androgen deprivation therapy (ADT).
Patients searching for Abirapro 250 mg Tablet, Abiraterone Acetate 250 mg, generic alternative to Zytiga, prostate cancer medicine, hormone therapy for prostate cancer, mCRPC treatment, or targeted prostate cancer therapy are referring to the same active ingredient. While Zytiga remains the most recognized originator brand globally, generic Abiraterone products continue to improve access to life-extending prostate cancer treatments across international markets.
Buy Abirapro 250 mg Tablets online from a trusted pharmaceutical supplier offering genuine oncology medicines, competitive pricing, secure ordering, and worldwide shipping where permitted by local regulations. Oncology medicines should only be used under the supervision of a qualified oncologist, with regular laboratory monitoring, liver function assessment, and individualized treatment planning.
Abirapro 250 mg Tablet is used to treat metastatic prostate cancer, including metastatic castration-resistant and metastatic castration-sensitive prostate cancer.
Abirapro contains Abiraterone Acetate, the same active ingredient found in Zytiga. Zytiga is the originator brand developed by Janssen Biotech.
Abiraterone inhibits the CYP17 enzyme, reducing androgen production and helping slow the growth of prostate cancer cells.
Prednisone is typically administered alongside Abiraterone to help reduce mineralocorticoid-related side effects such as fluid retention, hypertension, and low potassium levels.
Common side effects include fatigue, hypertension, fluid retention, elevated liver enzymes, joint pain, low potassium levels, and hot flashes.
Abiraterone is not considered curative for advanced prostate cancer but has demonstrated significant benefits in extending survival and delaying disease progression in appropriate patients.
Orders ship from our India Head Office within 1–2 business days of confirmation. We include full customs documentation — HS codes, certificates of origin, and pharmaceutical export permits.
Estimated delivery: 3–7 business days to UK. 7–10 business days to UAE, Saudi Arabia and Gulf countries. 10–15 days for USA and Asian countries.
All packages arrive in plain, unmarked brown boxes. No pharmacy name or medication details on the outside.
Only logged in customers who have purchased this product may leave a review.
Indraneel –
Delivered in time